Abstract: Four new endiandric acid analogues, tsangibeilin C (1), tsangibeilin D (2), tricyclotsangibeilin (3) and endiandric acid M (4), one new lignan, beilschminol B (5) and two new sesquiterpenes, (+)-5-hydroxybarbatenal (6) and (4R,5R)-4,5-dihydroxycaryophyll-8(13)-ene (7), together with four known compounds (8-11), were isolated from the roots of Beilschmiedia tsangii (Lauraceae). The structures of 1-7 were determined by spectroscopic techniques. Among the isolates, endiandric acid M (4) exhibited moderate iNOS inhibitory activity, with an IC 50 value of 31.70 µM.
Introduction
Over 40 species of Formosan lauraceous plants have been screened for anti-inflammatory activity using an inducible nitric oxide synthase (iNOS) assay. A methanolic extract of the roots of B. tsangii Merr. (Lauraceae) has shown potent inhibition of NO production, with no cytotoxicity against RAW 264.7 cells. B. tsangii is a medium-sized evergreen tree, distributed throughout Tonkin, Vietnam, southern and western China and southern Taiwan. About 200 Beilschmiedia species are found in these tropical regions, including two species in Taiwan [1] . Our previous study reported two new tetrahydrofuran-type lignans, beilschmin A and beilschmin B, two new 1-phenylbutyl benzoates, tsangin A and tsangin B, together with thirteen known compounds isolated from the stem of this plant [2] . One year later, three new epoxyfuranoid lignans, 4α,5α-epoxybeilschmin A, 4α,5α-epoxybeilschmin B and beilschmin D, together with nine known compounds, were obtained from the leaves [3] . More recently, six new endiandric acid analogues, tsangibeilin A, tsangibeilin B, endiandramide A, endiandric acid K, endiandric acid L and endiandramide B, two new lignans, beilschminol A and tsangin C, and six known compounds have been obtained from the roots of this species [4] . In this continuation of our research, four new endiandric acid analogues, tsangibeilin C (1), tsangibeilin D (2), tricyclotsangibeilin (3) and endiandric acid M (4), one new lignan, beilschminol B (5) and two new sesquiterpenes: (+)-5-hydroxybarbatenal (6) and (4R,5R)-4,5-dihydroxycaryophyll-8(13)-ene (7), together with four known compounds (8) (9) (10) (11) , have been isolated from the roots of this plant. The structures of 1-7 were determined by spectroscopic techniques. This paper elucidates the structures of 1-7 ( Figure 1 ). Endiandric acid M (4) exhibited moderate iNOS inhibitory activity, with an IC 50 value of 31.70 µM. 
Results and Discussion

Structure Elucidation
Compound 1 was isolated as a light yellowish oil. Its molecular formula was established as C 20 H 26 O 3 by ESIMS and HRESIMS, with eight unsaturated degrees. The IR spectrum showed absorptions at 1696 cm for a hydroxy group of carboxylic acid. These findings were supported by 13 C NMR spectrum. The 1 H, 13 C NMR (Table 1) . The rigid tetracyclic skeleton was indicated by HMBC correlations, including: H-5 to C-3, C-6, C-7 and C-14, H-3 to C-4, and C-7, H-13 to C-8 and C-10, H-8 to C-6 and C-10, H-9 to C-7, H-2 to C-3, C-4, C-11 and C-13, H-1 to C-3 and C-13, H-12 to C-3, C-9 and C-11 and H-11 to C-9. The relative configuration of 1, rel-(1S,3R,7R,10R,11S,12S,13S), was supported on the basis of NOESY ( Figure 3 ) and structural similarity with beilschmiedic acid D [5] . There are seven chiral centers in 1. However, in view of the observed optical rotation ([α] 23 D ± 0), 1 should be racemic, as are many endiandric acid analogues [6] [7] [8] [9] . According to the above data, the structure of 1 was elucidated and named tsangibeilin C. (Figure 2 ) experiments. The major differences between 1 and 2 were two hydroxy groups at C-6 and C-7 in 2 were substituted for the carboxyl group (δ 168.3, C-14) and H-7 [δ H 3.51 (1H, br s)] at C-6 and C-7 in 1, as supported by HRESIMS, IR and DEPT spectra. The NOESY spectrum ( Figure 3) showed correlations between H a -2, H-3 and H-11, but these three protons showed no correlations with H-1, H b -2, H-10, H-12 and H-13. This suggested that H a -2, H-3 and H-11 are on the same side of the molecule, and that H-1, H b -2, H-10, H-12 and H-13 are on the opposite side of the molecule. The β-orientation of the hydroxy group at C-7 was attributed according to the structural similarity with endiandric acid analogues and biogenetic consideration, where the rings A/B, B/C, C/D and B/D were cis-fusion and ring A/C was trans-fusion [4, 8, 9] . The relative configuration of 2, rel-(1S,3R,7R,10R,11S,12S,13S) was supported on the basis of NOESY and structural similarity with beilschmiedic acid D [5] . On the basis of the observations above, compound 2 was elucidated and named tsangibeilin D. (Table 2 ) and DEPT spectra indicated that 3 contains one methyl, eight methylenes, ten methines and one quaternary carbon. The HSQC and COSY ( Figure 2 ) spectra revealed three fragments, C1-C2-C3-C4-C5-C6, C1-C13-C11-C12-C1 and C-13-C14-C15-C9-C10, and the HMBC (Figure 2 ) correlations, H-10 to C-9, C-12, C-13 and C-15 and H-9 to C-11, connected the fragments C1-C13-C11-C12-C1 and C-13-C14-C15-C9-C10 to form a cyclohexane ring fused with a cyclobutane ring. The carboxyl group (δ 173.5, C-7) connected the fragment C1-C2-C3-C4-C5-C6 with the cyclohexane ring, as supported by HMBC correlations, H-6 to C-4, C-5 and C-7, H-5 to C-3 and C-7 and H-9 to C-7. According to the above evidence, the carboxyl group, the fragment C1-C2-C3-C4-C5-C6, the cyclohexane ring and the cyclobutane ring become a cyclododecane ring, which is also supported by six degrees of unsaturation. The HMBC spectrum showed correlations between H-1' and C-1, C-11, C-2' and C-3', thus establishing the presence of an alkyl chain (C-1'~C-6') to be connected at C-12. Finally, the HRESIMS, IR, and DEPT spectra indicated the presence of a hydroxy group located at C-10. The NOESY spectrum (Figure 3) showed correlations between H-9, H-10 and H-12, suggesting these three protons were on the same side of the molecule, but H-1, H-11 and H-13 showed no correlations with H-9, H-10 and H-12, which should therefore be on the opposite side of the molecule. The relative configuration of 3, rel-(1S,9R,10S,11R,12S,13S), was supported on the basis of NOESY and its structural similarity with know endiandric acid analogues. Based on further spectrographic evidence, the structure of 3 was elucidated and designated as tricyclotsangibeilin. (Table 2 ) spectra were similar to those of endiandric acid L, except that a methylene group [δ 2.78 (1H, dd, J = 15.6, 7.8 Hz, H a -1'), 2.81 (1H, br d, J = 7.8 Hz, H b -1')] in 4 replaced the pentamethylene group in endiandric acid L. The relative configuration of 4 was supported by NOESY spectrum and its structural similarity with endiandric acid L [4] . Thus, compound 4 was named endiandric acid M. Compounds 1, 2 and 4 were racemic, and all structures were determined by 13 C NMR, NOESY, COSY, HSQC and HMBC experiments (see Figures 2 and 3) . (Table 3 ) and DEPT spectra indicated that 7 contains three methyls, six methylenes, three methines and three quaternary carbons, suggesting a sesquiterpene skeleton. The HSQC and COSY (Figure 2 ) spectra revealed the correlations from C1-C9, C2-C3 and C-5-C6-C7 and the HMBC (Figure 2) correlations, H-1 to C-3, C-8 and C-11, H-10 to C-8, C-9 and C-11, H-9 to C-1 and C-8, H-7 to C-5, C-6, C-8 and C-9, H-6 to C-4, C-5 and C-8, H-3 to C-4 and C-5 and H-2 to C-1, C-3, C-4 and C-9, connected the fragments C1-C9, C2-C3 and C-5-C6-C7 to form a cyclononane ring and a cyclobutane ring. HMBC correlations, H-15 to C-1, C-10 and C-11, H-14 to C-10, C-11 and C-15, H-12 to C-3, C-4 and C-5, H-13 to C-7, C-8 and C-9, confirmed that three methyl groups were connected at C-4 and C-11 and that a terminal double bond was present at C-8. Finally, the HRESIMS, IR, DEPT spectra indicated two hydroxy groups located at C-4 and C-5, respectively. The NOESY spectrum (Figure 3) showed correlations between H b -7, H-9, H-12 and H-14, suggesting these three protons were on the same side of the molecule, but H-1, H-5, H a -7 and H-15 showed no correlations with H b -7, H-9, H-12 and H-14 and, therefore, should be on the opposite side of the molecule. The structure of 7 was elucidated as (4R, 5R)-4,5-dihydroxycaryophyll-8(13)-ene and identified with its synthetic compound [11] . Though compound 7 has previously been reported as a reduction intermediate [11] , our study is the first time to have isolated this compound from a natural source. The known compounds, 3,4,5-trimethoxybenzaldehyde (8) [12] , octahydro-4-hydroxy-3α-methyl-7-methylene-α-(1-methylethyl)-1H-indene-1-methanol (9) [13, 14] , eudesm-4(15)-ene-1β,6α-diol (10) [15, 16] and ursolic acid (11) [17] were identified by comparison of their physical and spectroscopic data with values reported in the literature. Table 4 . The technique for the anti-iNOS activity assay was the same as in our previous study [4] . Among the isolates, endiandric acid M (4) exhibited moderate iNOS inhibitory activity, with IC 50 value of 31.70 µM. Endiandramide B [4] , endiandric acids K [4] , L [4] and M, with the same skeleton but with different substituents at C-8, exhibited ascending degrees of iNOS inhibitory activity in this order: endiandramide B (16.40 µM) > endiandric acid M (4) (31.70 µM) > endiandric acid L (39.56 µM) > endiandric acid K (58.21 µM). This suggests that the potency of the substituent at C-8 was an N-isobutylamido group > an α,β-unsaturated carboxylic acid group > a carboxylic acid group. Endiandric acid M (4), with four fewer methylenes than endiandric acid L, showed stronger potency than endiandric acid L. This suggests that fewer methylenes in the alkyl side of endiandric acid analogues result in greater potency of iNOS inhibitory activity. (5) 55.62 ± 1.96 95.37 ± 0.52 ursolic acid (11) 36.55 ± 4.66 >100 6β-hydroxystigmast-4-en-3-one 
Anti-inflammatory Activities
Experimental Section
General Experimental Procedures
All melting points were measured on a Yanaco micro-melting apparatus and were uncorrected. Optical rotations were measured on a Jasco P-1020 digital polarimeter. The UV spectra were obtained with a Jasco V-530 UV/VIS spectrophotometer, and IR spectra (KBr or neat) were taken on a Perkin-Elmer System 2000 FT-IR spectrometer. 1D ( C, δ 49.0), with TMS as the internal standard. ESIMS were obtained on an API 3000 mass spectrometer (Applied Biosystems) and HRESIMS on a Bruker Daltonics APEX II 30e mass spectrometer. Silica gels (70-230, 230-400 mesh) (Merck) were used for column chromatography (CC), and silica gel 60 F-254 (Merck) was used for analytical and preparative TLC. A spherical C18 100A column (20-40 µM) (Silicycle) was used for medium-pressure liquid chromatography.
Plant Material
Roots of B. tsangii were collected at Mudan, Pingtung County, Taiwan, in April 2009 and identified by one of the authors (I.-S.C.). A voucher specimen (Chen 6120) was deposited in the Herbarium of the School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China.
Extraction and Isolation
The dried roots (7.9 kg) of B. tsangii were sliced and extracted three times with cold MeOH (10 L) at room temperature. The concentrated MeOH extract (280 g) inhibited nitrite production below 25%, with no observed cytotoxicity at 100 µg/mL. The MeOH extract was partitioned using EtOAc-H 2 O (1:1) to obtain EtOAc-soluble (120 g) and H 2 O-soluble (80 g) fractions. The EtOAc solubles (100 g) were applied to a silica gel CC and eluted with n-hexane-EtOAc gradient solvent system (15:1 to 100% EtOAc) to obtain 13 fractions (A-1-A-13). Fractions A-4-A-13 showed inhibition of nitrite production using the anti-iNOS assay, and the H 2 O-soluble fraction showed no inhibitory activity. CC of fraction A-8 (9.6 g) on silica gel, eluting with a gradient of CH 2 Cl 2 -EtOAc, yielded fractions A-8-1 to A-8-10. Fraction A-8-7-11 was subjected to MPLC and eluted with n-hexane: acetone (5:1) to yield 11 (5.7 mg). Fraction A-9 (17.8 g), on silica gel CC, eluting with a gradient of n-hexane-acetone, provided fractions A-9-1 to A-9-16. Fraction A-9-4 (104 mg) was applied to MPLC (RP-18) and eluted with acetone:H 2 O (1:1) to provide 7 (1.6 mg) and 15 fractions (A-9-4-1-A-9-4-15). Fraction A-9-4-12 (3.6 mg) was purified by preparative TLC (RP-18) and developed with n-hexane:EtOAc (2:1) to give 10 (3.2 mg). Fraction A-9-4-4 was treated with the same step as fraction A-9-4-12 to yield 9 (1.1 mg). Fraction A-9-9 (587 mg) was separated over MPLC (RP-18), eluting with a system of acetone:H 2 O (1:1), to afford fractions A-9-9-1 to A-9-9-21. Fraction A-9-9-2 (5 mg) and fraction A-9-9-10 (13.3 mg) were applied by preparative TLC developed with CH 2 Cl 2 :MeOH (70:1) and CH 2 Cl 2 :EtOAc (8:1) to give 8 (2.5 mg) and 5 (8.9 mg), respectively. Fraction A-9-9-20 (462 mg) was submitted to MPLC (RP-18) and eluted with acetone:H 2 O (3:1) to afford fractions A-9-9-20-1 to A-9-9-20-15. Fraction A-9-9-20-6 (63.8 mg) was subjected to MPLC (RP-18) and eluted with acetone:H 2 O (2:1) to afford fractions A-9-9-20-6-1 to A-9-9-20-6-12. Fraction A-9-9-20-6-3 (3.8 mg) and fraction A-9-9-20-6-7 (13.3 mg) were purified by preparative TLC (RP-18), developed with MeOH:H 2 O (5:1) and acetone: H 2 O (2:1), to give 1 (3.7 mg) and 2 (3.5 mg), respectively. 
Conclusions
There are about 200 Beilschmiedia species in the tropical regions mentioned earlier, including two species in Taiwan [1] . Except for the two species in Taiwan, previous studies of nine Beilschmiedia species in the world have revealed endiandric acids [5, 18, 19] , flavonoids [20, 21] , alkaloids [22] [23] [24] , benzopyrans [18] , arylpropanoids [25] and sesquiterpenoids [18] . Several isolates have shown antibacterial [19, 21] and antimalarial [22] activities. Phytochemical studies of the two Formosan Beilschmiedia species have been carried out by our group, analyzing the stems [2] , the leaves [3] and the roots [4] of B. tsangii, together with the roots [8, 9] of B. erythrophloia. Both species possess endiandric acids, 7,7'-epoxylignans, 7',8'-seco-7,7'-epoxylignans, benzopyrans, arylpropanoids, amides, sesquiterpenoids and steroids. In this study, endiandric acids, 7,7'-epoxylignans, benzenoid, sesquiterpenoids and triterpenoid were also reported. The constituents of the roots of the two Formosan Beilschmiedia species showed 19 new endiandric acid analogues as key secondary metabolites. The roots of other Beilschmiedia species found in other regions have not yet been studied. However, several isolates from two Formosan Beilschmiedia species have shown cytotoxic [2] , anti-tubercular [3, 9] or anti-inflammatory activities [4] in previous studies. These three bioactivities have not yet been examined in other members of the Beilschmiedia genus.
